These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6744290)

  • 21. Purification of estrogen receptors from MCF-7 human breast cancer cells.
    Chong MT; Lippman M
    Cancer Res; 1980 Sep; 40(9):3172-6. PubMed ID: 7427936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of the dextran-coated charcoal assay for estradiol receptor in breast cancer preparations.
    Shafie S; Brooks SC
    J Lab Clin Med; 1979 Nov; 94(5):784-98. PubMed ID: 501205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of estrogen and estrogen receptor in normal human melanocytes.
    Jee SH; Lee SY; Chiu HC; Chang CC; Chen TJ
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1407-12. PubMed ID: 8147884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytostatic and cytotoxic effects of tumor necrosis factor alpha on MCF-7 human breast tumor cells are differently inhibited by glucocorticoid hormones.
    Pagliacci MC; Fumi G; Migliorati G; Grignani F; Riccardi C; Nicoletti I
    Lymphokine Cytokine Res; 1993 Dec; 12(6):439-47. PubMed ID: 8123760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen binding sites in the nucleus of normal and malignant human tissue: optimization of an exchange assay for the measurement of specific binding.
    Syne JS; Markaverich BM; Clark JH; Panko WB
    Cancer Res; 1982 Nov; 42(11):4443-8. PubMed ID: 7127286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
    Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M
    Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear estradiol-binding sites in human breast cancer.
    Vandewalle B; Peyrat JP; Bonneterre J; Hecquet B; Dewailly D; Lefebvre J
    Cancer Res; 1983 Sep; 43(9):4497-503. PubMed ID: 6683589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7.
    Zheng ZY; Lin VC
    Cancer Lett; 2008 Sep; 268(2):202-11. PubMed ID: 18477500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific binding of estrogen and estrogen-receptor complex by microsomes from estrogen-responsive tissues of the rat.
    Watson GH; Muldoon TG
    Endocrinology; 1985 Oct; 117(4):1341-9. PubMed ID: 4029080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor status and subsequent sensitivity of subclones of MCF-7 human breast cancer cells surviving exposure to diethylstilbestrol.
    Brandes LJ; Hermonat MW
    Cancer Res; 1983 Jun; 43(6):2831-5. PubMed ID: 6850594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid hormone receptor studies in melanoma model systems.
    Markland FS; Horn D
    J Supramol Struct; 1980; 13(1):35-46. PubMed ID: 7442253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery of cellular E-cadherin precedes replenishment of estrogen receptor and estrogen-dependent proliferation of breast cancer cells rescued from a death stimulus.
    Malaguti C; Rossini GP
    J Cell Physiol; 2002 Aug; 192(2):171-81. PubMed ID: 12115723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.
    Girgert R; Bartsch C; Hill SM; Kreienberg R; Hanf V
    Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique.
    Eckert RL; Mullick A; Rorke EA; Katzenellenbogen BS
    Endocrinology; 1984 Feb; 114(2):629-37. PubMed ID: 6690295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture.
    Nawata H; Chong MT; Bronzert D; Lippman ME
    J Biol Chem; 1981 Jul; 256(13):6895-902. PubMed ID: 7240250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor transformation in MCF-7 breast cancer cells: characterization by immunochemical and sedimentation analyses.
    Miller MA; Greene GL; Katzenellenbogen BS
    Endocrinology; 1984 Jan; 114(1):296-8. PubMed ID: 6690275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.